This company seems to have been delisted
Reason: Acquired by Mars, Incorporated
Last recorded trade on: August 15, 2023
Source: https://www.mars.com/news-and-stories/press-releases-statements/mars-to-acquire-heska-global-provider-advanced-veterinary-solutions
Reason: Acquired by Mars, Incorporated
Last recorded trade on: August 15, 2023
Source: https://www.mars.com/news-and-stories/press-releases-statements/mars-to-acquire-heska-global-provider-advanced-veterinary-solutions
Heska Corporation
HSKA
A$184.14
Share price
0.00%
Change (1 day)
30.30%
Change (1 year)
Categories
Heska Corporation (HSKA) - Net assets
Net assets on the balance sheet as of March 2023 : A$0.64 Billion
According to Heska Corporation
's latest financial reports the company has A$0.64 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Heska Corporation - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $A$0.62 B | 3.2% |
| 2021-12-31 | $A$0.60 B | 61.04% |
| 2020-12-31 | $A$0.37 B | 69.32% |
| 2019-12-31 | $A$0.22 B | 26.89% |
| 2018-12-31 | $A$0.17 B | 35.06% |
| 2017-12-31 | $A$0.12 B | 6.62% |
| 2016-12-31 | $A$0.12 B | 38.36% |
| 2015-12-31 | $A$87.2 M | 34.32% |
| 2014-12-31 | $A$64.92 M | 22.91% |
| 2013-12-31 | $A$52.82 M | 12.34% |
| 2012-12-31 | $A$47.01 M | -0.47% |
| 2011-12-31 | $A$47.24 M | 4.78% |
| 2010-12-31 | $A$45.08 M | -10.11% |
| 2009-12-31 | $A$50.15 M | -16.79% |
| 2008-12-31 | $A$60.27 M | 22.88% |
| 2007-12-31 | $A$49.04 M | 473% |
| 2006-12-31 | $A$8.56 M | 93.74% |
| 2005-12-31 | $A$4.41 M | 32.58% |
| 2004-12-31 | $A$3.33 M | -62.78% |
| 2003-12-31 | $A$8.95 M | -45.22% |
| 2002-12-31 | $A$16.34 M | -51.4% |
| 2001-12-31 | $A$33.63 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 IDEXX Laboratories IDXX | A$2.22 B | 246.69% | 🇺🇸 USA |
 Eli Lilly LLY | A$24.31 B | 3,694.09% | 🇺🇸 USA |
 Petco WOOF | A$1.69 B | 165.12% | 🇺🇸 USA |
 Pfizer PFE | A$139.09 B | 21,600.57% | 🇺🇸 USA |
 Merck MRK | A$74.27 B | 11,488.07% | 🇺🇸 USA |
 Novartis NVS | A$59.00 B | 9,106.29% | 🇨🇭 Switzerland |
 Zoetis ZTS | A$7.14 B | 1,014.51% | 🇺🇸 USA |